Exelixis’ (EXEL) “Equal Weight” Rating Reiterated at Stephens
Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Stephens in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $29.00 price target on the biotechnology company’s stock. Stephens’ target price would indicate a potential downside of 15.92% from the company’s current […]
Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Stephens in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $29.00 price target on the biotechnology company’s stock. Stephens’ target price would indicate a potential downside of 15.92% from the company’s current […]
